DSM-Firmenich AG

DSM‑Firmenich AG extends its share‑repurchase program, boosting EPS, ROE and shareholder confidence while supporting a leaner equity base for long‑term value.

DSM-Firmenich AG has made significant strides in achieving its sustainability and financial goals, including sourcing 100% of its electricity from renewable sources, repurchasing a substantial amount of shares, and experiencing growth in key product…

DSM-Firmenich AG has achieved a major sustainability milestone by sourcing 100% of its electricity from renewable sources, while also strengthening its leadership team and making progress on its share repurchase program.

DSM-Firmenich AG has increased its share repurchase program to €1.08 billion, positioning the company for long-term success as it leverages its expertise in sustainable solutions and nutrition to capitalize on growing markets.

DSM-Firmenich AG is making progress on its share repurchase program, driven by the company’s goal to optimize its capital structure and capitalize on the rapidly growing global industrial enzyme market.

DSM-Firmenich AG has embarked on a strategic transformation, appointing a new president for its fine fragrance business and taking steps to optimize its financial structure and reduce debt.

DSM-Firmenich AG has taken bold steps to revamp its financial landscape by redeeming a €750 million hybrid bond and repurchasing €580 million worth of shares, signaling a commitment to financial prudence and potentially boosting investor confide…

DSM-Firmenich has partnered with Meala to commercialize texturizing protein for meat alternatives, aiming to drive innovation in the plant-based food sector.

DSM-Firmenich AG has completed the sale of its stake in Feed Enzymes Alliance, marking a significant step towards achieving its long-term goals and positioning the company for continued growth and success.

DSM-Firmenich AG has updated its share repurchase program, aiming to buy back CHF 500 million worth of shares to optimize its capital structure and return value to shareholders.